We are live on ! Find out more
IVLAV

Index Venture Life Associates VI Portfolio holdings

AUM $396M
1-Year Est. Return 176.22%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+176.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$167M
AUM Growth
Cap. Flow
+$165M
Cap. Flow %
98.94%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$165M
2
IPSC icon
Century Therapeutics
IPSC
+$256K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$167M 99.89%
+9,961,789
New +$165M
IPSC icon
2
Century Therapeutics
IPSC
$355M
$190K 0.11%
+188,251
New +$256K

Similar funds

Index Venture Life Associates VI's Q4 2024 Portfolio in Review

As of Q4 2024, Index Venture Life Associates VI held 2 positions worth $167M. Its ten largest holdings account for 100% of the portfolio.

Index Venture Life Associates VI deployed $165M of net new capital in Q4 2024, opening 2 new positions. Its largest new stake was Centessa Pharmaceuticals: 9,961,789 shares worth $167M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Index Venture Life Associates VI's largest Q4 2024 buy was Centessa Pharmaceuticals: 9,961,789 shares worth $167M.
  • Index Venture Life Associates VI's ten largest holdings make up 100% of its $167M portfolio in Q4 2024.
  • Index Venture Life Associates VI opened 2 new positions and closed 0 in Q4 2024.

Based on Index Venture Life Associates VI's 13F filing for Q4 2024, filed 14 Feb 2025.